Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 670

The DOI matches its Crossref record.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry

Delcroix, Marion, Lang, Irene, Pepke-Zaba, Joanna, Jansa, Pavel, D’Armini, Andrea M., Snijder, Repke, Bresser, Paul, Torbicki, Adam, Mellemkjaer, Sören, Lewczuk, Jerzy, Simkova, Iveta, Barberà, Joan A., de Perrot, Marc, Hoeper, Marius M., Gaine, Sean, Speich, Rudolf, Gomez-Sanchez, Miguel A., Kovacs, Gabor, Jaïs, Xavier, Ambroz, David, Treacy, Carmen, Morsolini, Marco, Jenkins, David, Lindner, Jaroslav, Dartevelle, Philippe, Mayer, Eckhard, Simonneau, Gérald·2016·Circulation

Abstract

Background—: Chronic thromboembolic pulmonary hypertension, a rare complication of acute pulmonary embolism, is characterized by fibrothrombotic obstructions of large pulmonary arteries combined with small-vessel arteriopathy. It can be cured by pulmonary endarterectomy, and can be clinically improved by medical therapy in inoperable patients. A European registry was set up in 27 centers to evaluate long-term outcome and outcome correlates in 2 distinct populations of operated and not-operated patients who have chronic thromboembolic pulmonary hypertension. Methods and Results—: A total of 679 patients newly diagnosed with chronic thromboembolic pulmonary hypertension were prospectively included over a 24-month period. Estimated survival at 1, 2, and 3 years was 93% (95% confidence interval [CI], 90–95), 91% (95% CI, 87–93), and 89% (95% CI, 86–92) in operated patients (n=404), and only 88% (95% CI, 83–91), 79% (95% CI, 74–83), and 70% (95% CI, 64–76) in not-operated patients (n=275). In both operated and not-operated patients, pulmonary arterial hypertension–targeted therapy did not affect survival estimates significantly. Mortality was associated with New York Heart Association functional class IV (hazard ratio [HR], 4.16; 95% CI, 1.49–11.62; P =0.0065 and HR, 4.76; 95% CI, 1.76–12.88; P =0.0021), increased right atrial pressure (HR, 1.34; 95% CI, 0.95–1.90; P =0.0992 and HR, 1.50; 95% CI, 1.20–1.88; P =0.0004), and a history of cancer (HR, 3.02; 95% CI, 1.36–6.69; P =0.0065 and HR, 2.15; 95% CI, 1.18–3.94; P =0.0129) in operated and not-operated patients, respectively. Additional correlates of mortality were bridging therapy with pulmonary arterial hypertension–targeted drugs, postoperative pulmonary hypertension, surgical complications, and additional cardiac procedures in operated patients, and comorbidities such as coronary disease, left heart failure, and chronic obstructive pulmonary disease in not-operated patients. Conclusions—: The long-term prognosis of operated patients currently is excellent and better than the outcome of not-operated patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.016522

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 670

Metadata

Authors
Delcroix, M., Lang, I., Pepke-Zaba, J., Jansa, P., D’Armini, A. M., Snijder, R., Bresser, P., Torbicki, A., Mellemkjaer, S., Lewczuk, J., Simkova, I., Barberà, J. A., de Perrot, M., Hoeper, M. M., Gaine, S., Speich, R., Gomez-Sanchez, M. A., Kovacs, G., Jaïs, X., Ambroz, D., Treacy, C., Morsolini, M., Jenkins, D., Lindner, J., Dartevelle, P., Mayer, E., & Simonneau, G.
Venue
Circulation
Published
2016-03
Volume
133
Issue
9
Pages
859-871
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2261574050
Cited by
670
References
0
FWCI
45.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. https://app.cochat.ai/papers/10.1161/circulationaha.115.016522
The paper
Delcroix, M., Lang, I., Pepke-Zaba, J., Jansa, P., D’Armini, A. M., Snijder, R., Bresser, P., Torbicki, A., Mellemkjaer, S., Lewczuk, J., Simkova, I., Barberà, J. A., de Perrot, M., Hoeper, M. M., Gaine, S., Speich, R., Gomez-Sanchez, M. A., Kovacs, G., Jaïs, X., . . . Simonneau, G. (2016). Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. https://doi.org/10.1161/circulationaha.115.016522

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.